A 77-year-old man with recurrent glioblastoma has become the first patient in Israel to undergo an experimental Alpha DaRT treatment as part of a clinical trial at Hadassah Ein Kerem Medical Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results